logo

Glycomimetics, Inc. (GLYC)



Trade GLYC now with
  Date
  Headline
4/12/2019 9:12:57 AM GlycoMimetics Plans To Initiate Clinical Trial Of GMI-1359 In Breast Cancer Patients Whose Tumors Have Spread To Bone
11/2/2018 7:45:45 AM GlycoMimetics Q3 Loss Per Share $0.27 Vs Loss $0.24 Last Year
5/30/2018 9:20:34 AM GlycoMimetics Signs Cooperative Research And Development Agreement With The National Cancer Institute
5/3/2018 7:19:06 AM GlycoMimetics Posts Q1 Net Loss Of $11.51 Mln Or $0.33/share
3/20/2018 9:38:59 PM GlycoMimetics Announces Pricing Of Underwritten Public Offering Of 7 Mln Shares At $17.00/shr
3/19/2018 4:03:29 PM GlycoMimetics Announces Proposed Public Offering Of Common Stock
3/6/2018 7:34:58 AM GlycoMimetics Q4 Loss Per Share $0.27 Vs Loss $0.36 Last Year
12/12/2017 7:01:55 AM GlycoMimetics Announces Updated Data From Phase 1/2 Trial Evaluating Safety, Tolerability And Efficacy Of GMI-1271